Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQFinancialsInsurance - Property & CasualtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for PRHI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
net income improves to positive territory | Net income rose to $2.6M in 2026-Q1 from a $17M loss in 2025-Q4. | Improving | net income falls below $0 (loss) in next 4 quarters | Net income: $2.536M FY2026-Q2; GAAP. Published target: >= $2.6M net income. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 12, 20262,536,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround in a financial company, not a steady compounder. The thesis is on watch: the signal recently improved from mixed to mildly favorable, but earnings quality is still classified as loss-making and recent performance remains weak.
PRHI is tagged as cheap versus peers, while the model describes pricing as justified and finds low fragility. The expectations gap is close to neutral, so the evidence does not point to a large gap between market expectations and the current setup.
Near term, results may remain uneven: the company is smaller, recent earnings surprises have been erratic, and the next call could bring a guidance cut. Over the multi-year view, management’s underwriting focus has some support from a sharp combined-ratio improvement and higher adjusted operating income in the second quarter, though the snapshot still rates overall performance as weak.
The thesis depends on whether better underwriting and profitability continue beyond the recent quarter. A guidance cut would be a meaningful negative, while continued earnings strength from sector bellwethers such as CB, PGR, and TRV would support the sector backdrop. The rate outlook is another swing factor, since the evidence says rate cuts would weigh on financial companies.
Over the next 1 to 3 years, PRHI’s long-term thesis rests on turning recent operating progress into consistent results, with high risk and limited evidence of a durable recovery so far. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in PRESURANCE HOLDINGS INC's published investment case. The stated target is no Nasdaq delisting notices. |
| Under Pressure |
| receives new Nasdaq delisting notice or fails to resolve listing issues |
Nasdaq delisting notice received vs no notices target Nasdaq notice received March 2026 for bid price below $1.00 for 30 consecutive days. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
revenue grows significantly | A primary condition in PRESURANCE HOLDINGS INC's published investment case. The stated target is >= $11.5M revenue. | Improving | revenue falls below $4.6M in next 4 quarters | Revenue: $9.142M FY2026-Q2; GAAP. Published target: >= $11.5M revenue. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 12, 20269,142,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.